Description
This research blend contains CJC-1295 without DAC (5mg) and Ipamorelin (5mg), totaling 10mg of material. CJC-1295 without DAC, commonly associated with Modified GRF (1-29), is a 29-residue analog related to growth hormone-releasing hormone, while Ipamorelin is a synthetic pentapeptide investigated as a ghrelin/growth-hormone-secretagogue receptor ligand. The combination is used in controlled research examining two distinct receptor pathways within the somatotropic signaling axis. For research use only; not for human or veterinary use.
